Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D(3) as host directed therapy

BACKGROUND: We have previously shown that 8 weeks’ treatment with phenylbutyrate (PBA) (500mgx2/day) with or without vitamin D(3) (vitD(3)) (5000 IU/day) as host-directed therapy (HDT) accelerated clinical recovery, sputum culture conversion and increased expression of cathelicidin LL-37 by immune c...

全面介紹

Na minha lista:
書目詳細資料
發表在:BMC Infect Dis
Main Authors: Rekha, Rokeya Sultana, Mily, Akhirunnesa, Sultana, Tajnin, Haq, Ahsanul, Ahmed, Sultan, Mostafa Kamal, S. M., van Schadewijk, Annemarie, Hiemstra, Pieter S., Gudmundsson, Gudmundur H., Agerberth, Birgitta, Raqib, Rubhana
格式: Artigo
語言:Inglês
出版: BioMed Central 2018
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6033279/
https://ncbi.nlm.nih.gov/pubmed/29973153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-018-3203-9
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍